Skip to content
by Legal Desire
SIGN IN GO PRO
Lawyer profile

Ben Haas

Latham & Watkins LLP
Claim this profile
Firm
Latham & Watkins LLP
Practice
FDA, FDA and healthcare regulatory, FDA regulation
Office
Washington DC, Washington, D.C.
Active in the record
2020 to 2026

Deal experience

Deal types
Banking & FinanceCapital Markets & IPODebt Capital MarketsM&AOtherPrivate Equity & BuyoutsRestructuring & InsolvencyVenture Capital & Growth
Sectors
Agriculture & FoodConsumer & RetailFinancial ServicesHealthcare & Life Sciences
Jurisdictions
ChinaGermanyUnited KingdomUnited States

Recent deals

29 announced deals in the record
Latham Advises Medical Faculty Associates in Transaction With the George Washington University and Universal Health Services 11 Aug 2026
Restructuring & Insolvency Healthcare & Life Sciences Latham & Watkins LLP Lead Healthcare & Life Sciences Washington, D.C.
Latham & Watkins Advises CordenPharma on Acquisition of AmbioPharm 4 Aug 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP life sciences and regulatory Washington, D.C.
Latham Advises AIR Limited in Business Combination With Cantor Equity Partners III and Nasdaq Listing 25 May 2026
Capital Markets & IPO Latham & Watkins LLP healthcare and life sciences
Latham & Watkins Advises on Medline’s Upsized Landmark US$7.2 Billion IPO 19 Dec 2025
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 7.20bn FDA regulatory
Latham & Watkins Advises Clario in US$8.875 Billion Sale to Thermo Fisher Scientific 4 Nov 2025
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 8.88bn FDA regulatory Washington, D.C.
Latham & Watkins Advises MyHealthTeam in Acquisition by Swoop 8 Jan 2025
M&A Healthcare & Life Sciences Latham & Watkins LLP FDA regulatory Washington, D.C.
Latham & Watkins Advises on Gilead Sciences’ US$3.5 Billion Senior Unsecured Notes Offering 21 Nov 2024
Capital Markets & IPO Financial Services Latham & Watkins LLP USD 3.50bn FDA regulatory Washington, D.C.
Latham & Watkins Advises SLR Capital on Completed Vapotherm Merger and Take-Private 28 Sept 2024
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 83m FDA regulatory Washington, D.C.
Latham & Watkins Advises Ascendis Pharma in US$150 Million Royalty Financing 9 Sept 2024
Debt Capital Markets Healthcare & Life Sciences Latham & Watkins LLP USD 150m FDA regulatory
Latham & Watkins Advises Seres Therapeutics in VOWST Asset Purchase Agreement With Nestlé Health Science 7 Aug 2024
M&A Healthcare & Life Sciences Latham & Watkins LLP FDA regulatory
Deal alerts PRO

Get an email when Ben Haas is named on a newly announced deal.

See Pro plans

Alerts come as one daily email at most.

Pro

See all 29 deals for Ben Haas

This page shows the 10 most recent. The paid plans open the complete history for this lawyer, with full filtering, plus:

  • Complete deal history, filtered by keyword, deal type, sector and year
  • Deals by year, sector and deal type
  • Frequent co-counsel and the firms most often on the other side
  • Repeat clients, as named in the announcements
  • CSV and Excel export
SEE PLANS SIGN IN
Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction